^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Bloodhound™ BCR::ABL1 Assay

    Company:
    Precipio
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    At Precipio’s clinical lab, our Bloodhound quantitative BCR-ABL1 molecular panel goes beyond standard breakpoint testing. It provides comprehensive results in a simple workflow. The assay’s 0.001% limit of detection (LoD) offers superior MRD monitoring for four breakpoints (p.190, p.203, p.210, & p.230).
    Cancer:
    Chronic Myeloid Leukemia
    Gene:
    ABL1 (ABL proto-oncogene 1), BCR (BCR Activator Of RhoGEF And GTPase)
    Method:
    PCR